Yahong Pharmaceutical (688176.SH) disclosed its semi-annual report for 2024, and the company achieved a revenue of 8,049 million yuan during the reporting period...
Zhitong Finance APP News, Yahong Pharmaceutical (688176.SH) disclosed its semi-annual report for 2024, and the company achieved a revenue of 80.49 million yuan, a year-on-year increase of 103,397.96%; the net loss attributable to the parent company was 0.184 billion yuan, a year-on-year narrowing. The non-recurring net loss was 0.197 billion yuan, a year-on-year narrowing; the basic earnings per share was -0.32 yuan.
